Back to top
more

PetMed Express (PETS)

(Delayed Data from NSDQ)

$3.20 USD

3.20
108,233

-0.04 (-1.23%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $3.18 -0.02 (-0.63%) 7:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (153 out of 246)

Industry: Internet - Commerce

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Amazon Takes Prime to Singapore, Focuses on Southeast Asia

by Zacks Equity Research

Amazon.com Inc. (AMZN) launches Prime in Singapore in a bid to expand its presence in Southeast Asia.

    Zacks Equity Research

    Hologic's Panther Fusion Flu AdV/hMPV/RV Assay Wins FDA Nod

    by Zacks Equity Research

    Hologic's (HOLX) recent spree of regulatory approvals for its array of products is encouraging.

      Zacks Equity Research

      Chemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival

      by Zacks Equity Research

      Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.

        Zacks Equity Research

        Walgreens Boots Invests in China to Fortify Retail Pharmacy

        by Zacks Equity Research

        Walgreens Boots' (WBA) decision to buy a minority stake in Sinopharm Holding Guoda Drugstores is likely to leverage its global pharmacy expertise.

          Zacks Equity Research

          Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio

          by Zacks Equity Research

          Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.

            Zacks Equity Research

            Hologic Banks on Molecular Diagnostics, Competition Rife

            by Zacks Equity Research

            Hologic (HOLX) gains on increasing market share and utilization of fully-automated Panther system.

              Zacks Equity Research

              Here's Why You Should Add Garmin (GRMN) to Your Portfolio

              by Zacks Equity Research

              Garmin Ltd. (GRMN) continues to perform well, driven by differentiated products, diversification and innovation strategy.

                Zacks Equity Research

                4 Retail Growth Stocks to Make Your Christmas Fest Special

                by Zacks Equity Research

                If you wish to make merry this Christmas holidays, you still got time to add that extra jingle to your portfolio by adding growth stocks.

                  Zacks Equity Research

                  Veeva Systems (VEEV) Beats on Earnings in Q3, Updates View

                  by Zacks Equity Research

                  Veeva Systems (VEEV) witnesses year-over-year growth in revenues on strength in subscription and professional services in Q3.

                    Zacks Equity Research

                    Here's Why You Should Invest in PetMed (PETS) Stock Now

                    by Zacks Equity Research

                    PetMed's (PETS) implements strategies to revitalize top line. It also offers a comprehensive portfolio.

                      Zacks Equity Research

                      IDEXX Laboratories Banks on Global Prospects, CAG Strength

                      by Zacks Equity Research

                      IDEXX Laboratories (IDXX) rides on strength across all segments, especially CAG. Strong fundamentals buoy optimism.

                        Zacks Equity Research

                        Align Technology Rides High on InvisAlign & Strategic Pacts

                        by Zacks Equity Research

                        Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).

                          Zacks Equity Research

                          Amazon (AMZN) Rules E-Commerce: 3 Contenders to Watch Out

                          by Zacks Equity Research

                          Companies like EVINE Live Inc. (EVLV), PetMed Express, Inc. (PETS) and Wal-Mart Stores Inc. (WMT) are likely to gain from the growing e-commerce market.

                            Zacks Equity Research

                            The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                            by Zacks Equity Research

                            The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                              Zacks Equity Research

                              First Data (FDC) Acquires BluePay, Boosts Service Offerings

                              by Zacks Equity Research

                              First Data Corporation (FDC) acquires BluePay Holdings to expand its offerings in the high-growth integrated payments space.

                                Zacks Equity Research

                                Ecolab Focuses on Pest Elimination, Acquires 3 Companies

                                by Zacks Equity Research

                                Ecolab (ECL) continues to focus on investment in key growth businesses and bolt-on acquisitions to gain market traction and boost profits and inorganic growth.

                                  Zacks Equity Research

                                  Quest Diagnostics Banks on Buyouts to Expand in Diagnostic

                                  by Zacks Equity Research

                                  Quest Diagnostics (DGX) actively pursues merger and acquisitions to solidify hold in the high-potential diagnostic information services market. Notably, Cleveland HeartLab buyout marks as the latest deal.

                                    Zacks Equity Research

                                    Patterson Companies-SprintRay Deal to Boost Dental Unit

                                    by Zacks Equity Research

                                    Patterson Companies (PDCO) focuses on acquisitions to boost dental segment.

                                      Zacks Equity Research

                                      CVS Health's Aetna Buyout to Change Healthcare Landscape

                                      by Zacks Equity Research

                                      Once the Aetna deal is through, CVS Health (CVS) expects to draw $750 million from near-term synergies with low to mid-single digit accretion in the second year.

                                        Zacks Equity Research

                                        Cooper Companies' (COO) CooperVision Buys Paragon for $80M

                                        by Zacks Equity Research

                                        The Cooper Companies (COO) focuses on strategic acquisitions to drive inorganic growth.

                                          Zacks Equity Research

                                          Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay

                                          by Zacks Equity Research

                                          Boston Scientific (BSX) announces a delay in deadline for the commercial return of the LOTUS Edge Aortic Valve System in Europe. Following this news, share price declines.

                                            Zacks Equity Research

                                            BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo

                                            by Zacks Equity Research

                                            BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.

                                              Zacks Equity Research

                                              ResMed (RMD) Rides on Innovation Amid Reimbursement Woes

                                              by Zacks Equity Research

                                              ResMed (RMD) achieves strong global revenue growth for the past few quarters on the back of sales of sleep devices, respiratory care devices, mask systems and software solutions.

                                                Zacks Equity Research

                                                Here's Why You Should Add Chemed (CHE) to Your Portfolio Now

                                                by Zacks Equity Research

                                                Chemed (CHE) continues to ride high on strength in Roto-Rooter business.

                                                  Zacks Equity Research

                                                  Bio-Rad (BIO) at a 52-Week High: What's Driving the Stock?

                                                  by Zacks Equity Research

                                                  Bio-Rad (BIO) consistently invests in R&D for product innovation.